GlassScriptPhysician profile
Bobby M Oommen
NPI 1750532958
$8,088.10
in general payments reported to CMS, 2019-2025
29 companies · $614 in 2025
The $614 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,342 · 2020: $704 · 2021: $751 · 2022: $417 · 2023: $2,358 · 2024: $1,902 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,461 · Travel and Lodging: $2,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,461.14 |
| Travel and Lodging | $2,413.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $1,946.58 | 2022-2023 | Intracept |
| Boston Scientific Corporation | $1,702.22 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic, INC. | $1,344.16 | 2023-2024 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $531.91 | 2019-2024 | Proclaim |
| Spr Therapeutics, INC | $389.19 | 2023-2025 | Sprint Pns System |
| Mml US, INC. | $357.52 | 2024-2025 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $328.47 | 2019-2021 | |
| Pfizer INC. | $199.88 | 2019-2021 | |
| Saluda Medical Americas, INC. | $194.45 | 2024-2025 | Evoke |
| Scilex Pharmaceuticals INC. | $149.59 | 2019-2020 | |
| Allergan, INC. | $138.76 | 2019-2020 | |
| Abbvie INC. | $119.24 | 2021 | |
| Curonix LLC | $90.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $80.75 | 2020 | |
| Amgen INC. | $76.04 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $68.55 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.81 | 2019-2020 | |
| Vertos Medical, INC. | $48.02 | 2021-2023 | Mild Device Kit |
| Biodelivery Sciences International, INC. | $36.75 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $35.25 | 2021 | |
| Lilly USA, LLC | $31.00 | 2019-2020 | |
| Baxter Healthcare | $29.15 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic Vascular, INC. | $27.63 | 2019 | |
| Horizon Therapeutics Plc | $24.02 | 2021 | |
| Grt US Holding, INC. | $20.67 | 2021 | |
| Fidia Pharma USA INC. | $20.48 | 2019 | |
| Depuy Synthes Sales INC. | $14.32 | 2019 | |
| Nalu Medical, INC. | $14.29 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Oommen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.